Nvelop Therapeutics Revenue

Biotechnology Research • Cambridge, Massachusetts, United States • 1-10 Employees

Nvelop Therapeutics revenue & valuation

Annual revenue	$769,995
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$2,500,000
Total funding	$100,000,000

Key Contacts at Nvelop Therapeutics

Neil Marshall

Owner | Senior Software Consultant

Peter Cabeceiras

Co-Founder & Senior Scientist

Company overview

Headquarters	100 Technology Square, Cambridge, Massachusetts 02139, US
Phone number	+120232024
Website	nveloptx.com
NAICS	541714
Founded	2022
Employees	1-10
Socials

Nvelop Therapeutics Email Formats

Nvelop Therapeutics uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@nveloptx.com), used 80% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@nveloptx.com	80%
{first name}{last name}	johndoe@nveloptx.com	20%

About Nvelop Therapeutics

At Nvelop, we are working to address the complex challenge of effectively delivering genetic medicines to target cells within the body (in vivo) in order to help treat patients with previously undruggable diseases. Our team is advancing two next-generation delivery platforms, started in the labs of our scientific co-founders Dr. David Liu of the Broad Institute of MIT and Harvard, and Dr. Keith Joung formerly of Mass General Hospital. We will use these platforms to build a pipeline of therapeutics internally and to enable strategic partners. We are building a culture and organization to support this important mission, bringing together individuals that thrive in a supportive environment where diverse perspectives and a passion for discovery drive cutting-edge science and breakthrough medicines. Read something that resonates? Reach out to careers@NvelopTx.com.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Entry

Senior

Founder/Owner

Employees by Department

Nvelop Therapeutics has 6 employees across 3 departments.

Departments

Number of employees

Funding Data

Explore Nvelop Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-10-20	3	$100,000,000

Funding Insights

$100,000,000

Total funding amount

$100,000,000

Most recent funding amount

Number of funding rounds

Nvelop Therapeutics Tech Stack

Discover the technologies and tools that power Nvelop Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Cloudflare Bot Management

Security

Ninja Forms

Form builders

Marionette.js

JavaScript frameworks

Underscore.js

JavaScript libraries

Microsoft 365

jQuery Migrate

JavaScript libraries

Cloudflare

CDN

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

HTTP/3

Miscellaneous

PHP

Programming languages

WordPress

Blogs

Frequently asked questions

Nvelop Therapeutics is located in Cambridge, Massachusetts, US.

You can reach Nvelop Therapeutics at +120232024.

Nvelop Therapeutics generates an estimated annual revenue of $769,995. This revenue figure reflects the company's market position and business performance in its industry.

Nvelop Therapeutics has an estimated valuation of $2,500,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Nvelop Therapeutics was founded in 2022, making it 4 years old. The company has established itself as a significant player in its industry over this time.

Nvelop Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Nvelop Therapeutics has raised a total of $100,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Nvelop Therapeutics

Neil Marshall

Owner | Senior Software Consultant

Peter Cabeceiras

Co-Founder & Senior Scientist

4.8

40,000 users